Primary Progressive Multiple Sclerosis

Goal: Developed from the MURDOCK Multiple Sclerosis Study, this study  seeks to understand the development and progression of the primary progressive sub-type of MS, which is characterized by a continuous display of symptoms, rather than periods of relapse and remission.  Approximately 10% of MS patients are afflicted by primary progressive MS, yet no treatment has proven successful for this sub-type.

 

Principal Investigator: Dr. Simon Gregory

 

WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.